Portrai Inc.

Portrai Inc., a trailblazing biotech firm from Seoul, South Korea, is revolutionizing the field of drug development with its innovative application of spatial transcriptomics and AI. Specializing in identifying novel biomarkers and therapeutic targets for solid cancers and neurodegenerative disorders, Portrai’s cutting-edge technology offers a new lens to understand complex diseases at the tissue level. Our platforms, PortraiTARGET, PortraiDRUG, PortraiMIX, and PortraiTME, seamlessly integrate AI algorithms with spatial transcriptomic data, unlocking unprecedented insights into cellular interactions and gene expression within tumors.

With a robust portfolio of patents and a growing database of spatial transcriptomic data from diverse patient samples, Portrai stands at the forefront of precision medicine. Their approach not only accelerates drug discovery but also tailors treatments to individual patient needs, marking a significant leap in personalized healthcare.